Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study
Critical Care Medicine,  Clinical Article

Makris D et al. – This study provides evidence that pravastatin may favorably affect the outcome of critical care patients.

  • Consecutive patients were recruited from the intensive care units of the two hospitals.
  • Patient inclusion criteria included mechanical ventilation and intensive care unit stay of >48 hrs.
  • The two arms consisted of treatment plus oral pravastatin sodium (40 mg) (n=71 patients, pravastatin group) and treatment without pravastatin (n=81 patients, control group).
  • Treatment was started after randomization and ended 30 days later.

  • Ventilator-associated pneumonia frequency and intensive care unit mortality at 30 days and at the end of intensive care unit stay were measured.
  • Adverse events related to statin treatment in the intensive care unit were documented.
  • Sixteen patients (22.5%) in the pravastatin group and 28 (34.5%) in the control group (p=.11) presented pneumonia during the 30-day treatment period in the intensive care unit.
  • There was an indication for increased probability of being free from ventilator-associated pneumonia during the 30-day treatment period in the pravastatin group compared to the control group (p=.06) and significantly increased probability during the whole intensive care unit period of stay (p=.04) in the pravastatin group compared to the control group in the subgroup of patients with Acute Physiology and Chronic Health Evaluation scores of ≥15.
  • Six patients (8.45%) in the pravastatin group and 16 (19.85%) in the control group died during the 30-day treatment period (p=.06), whereas 10 (14.1%) patients in the pravastatin group and 24 (29.1%) patients in the control group died during the whole period of intensive care unit stay (p=.03).
  • Pravastatin group patients with Acute Physiology and Chronic Health Evaluation scores of ≥15 had significantly increased probability of survival compared to controls during the 30-day treatment period (p=.04).
  • Creatine kinase and hepatic function enzyme levels during the whole study period were not significantly different between the pravastatin group and control group.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis Chest, September 9, 2014    Clinical Article

3 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

4 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

5 Cardiac glycosides use and the risk of lung cancer: A nested case–control study Full Text BMC Cancer, August 22, 2014    Free full text    Clinical Article

6 Risk of dementia among patients with asthma: a nationwide longitudinal study Journal of the American Medical Directors Association, August 28, 2014    Clinical Article

7 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

8 Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: A randomised, double-blind, placebo-controlled, phase 2a study The Lancet Respiratory Medicine, September 16, 2014    Clinical Article

9 The use of N-acetylcysteine in respiratory diseases Current Respiratory Medicine Reviews, July 17, 2014    Review Article

10 Cost-effectiveness of salmeterol/fluticasone propionate combination (Advair) in uncontrolled asthma in Canada Respiratory Medicine, September 22, 2014    Clinical Article

11 Volume assured versus pressure preset non-invasive ventilation for compensated ventilatory failure in COPD Respiratory Medicine, September 23, 2014    Clinical Article

12 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

13 Value of different bronchoscopic sampling techniques in diagnosis of sarcoidosis: A prospective study of 151 patients Journal of Bronchology & Interventional Pulmonology, July 21, 2014    Clinical Article

14 Once-daily indacaterol 75 µg in moderate- to-severe COPD: Results of a Phase IV study assessing time until patients’ perceived onset of effect Full Text International Journal of COPD, September 10, 2014    Free full text    Clinical Article

15 SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial Respiratory Medicine, September 24, 2014    Clinical Article

16 Combination long-acting {beta}-agonists and inhaled corticosteroids compared with long-acting {beta}-agonists alone in older adults with chronic obstructive pulmonary disease JAMA, September 18, 2014    Evidence Based Medicine    Clinical Article

17 Association between serum angiotensin-converting enzyme 2 level with postoperative morbidity and mortality after major pulmonary resection in non-small cell lung cancer patients Heart, Lung, and Circulation, September 12, 2014    Clinical Article

18 Interactive videogame as rehabilitation tool of patients with chronic respiratory diseases: Preliminary results of a feasibility study Respiratory Medicine, September 17, 2014    Clinical Article

19 A randomized study of formoterol fumarate in a porous particle metered-dose inhaler in patients with moderate-to-severe COPD Respiratory Medicine, September 25, 2014    Clinical Article

20 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More